Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Selection by itch relief may create the apparent benefit of removing skin irritants

Selecting people with equal itch relief after treatment may make appear to shorten the time between warning and skin damage. The hypothesis predicts equivalent and estimated in the full ; a persistent would reject it.

Stage of verification

  1. Hypothesis published2026-09-25
  2. Not enough research data
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Biological function

Sensory warning of potentially damaging heat and pressure on the skin, allowing time for protective action

Direction

Lens

Puts the cause in the measurement rather than the biology: the instrument, or the definition of what is being counted, produces the result.Measurement and interpretation

Kind of knowledge gap

The available measurement is only an indirect stand-in for what matters.Proxy gap

A double ring marks the main placement where a group contains several values.

Goal
Совместимость защитных реакций при одновременных нагрузках
Competing hypotheses
2
Published
2026-09-25
As a hypothesis
8 / 10Clarity of mechanism
10 / 10Few extra conditions
9 / 10Completeness of the answer
3 / 10Novelty of the idea
10 / 10Few new entities
7 / 10Decisive experiment
0 / 10Silver-bullet potential
Not ratedSupport from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Scale or classification

    Treatment response classification

    Grouping participants according to their response to treatment

    Where this hypothesis actsComparisons of interventions with equal itch reduction in participants with skin damage

    Hypotheses on this target 1
    Treatment response classificationTelling states apart. Hypotheses on this target 11Direct measurement. Hypotheses on this target 0Indicator replacement. Hypotheses on this target 0
    • Telling states apart1
    • Direct measurement
    • Indicator replacement

    What is proposed

    Telling states apart

    Describe itch reduction as an outcome without using it as the sole inclusion criterion

    With whatNot stated in the record

    HowAssign interventions before treatment, analyse all enrolled participants, and compare with analyses restricted to participants with equal itch reduction

    Possible result

    Expected equivalence in and when all enrolled participants are analysed

    From the recordРавное уменьшение зуда следует описывать как результат, а не использовать как единственный критерий включения в сравнение.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsViable pathogen burden. Hypotheses on this target 1Viable pathogen burdenTreatment response classification. Hypotheses on this target 1Treatment response classification

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Relieving itchy skin may change how reliably discomfort warns of approaching injury. The unexpected move is to locate an apparent safety difference in which participants are compared: keeping only people whose itch improved equally could make one treatment look more dangerous. This is a proposal generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. Treatment choice, starting and skin damage jointly influence how much itch improves.
  2. retains only participants whose itch improves by the same amount.
  3. That selection turns initially comparable treatment groups into selected groups that may differ in their starting risk of late warning and injury.
  4. Those starting differences produce an apparent treatment difference in the interval between warning and injury.
  5. The comparison attributes that difference to even though the hypothesis proposes no additional shortening of that interval from the studied treatment.
A picture for it

Comparing two repair methods only among roofs whose leaks improved equally can be misleading if both the repair method and the roof's starting condition determine improvement. The selected roofs may have started in different condition even if the methods were originally assigned by chance.

Where the picture breaks: Roofs do not sense danger or change their protective responses. The picture explains how selecting by improvement can distort a comparison, but supplies no evidence that this happens with itch treatments.

  1. Master questionstep 01 of 04

    A therapy should restore the functioning of middle-aged people's skin toward that of young people's skin.

    Rests on: The stated goal identifies younger skin function as the target, without specifying which functions would establish that the target had been reached.

    Assumption

    The goal assumes that younger skin function provides a suitable treatment target; the supplied material gives no operational definition of that target.

  2. Goal pillarstep 02 of 04

    Skin's protective responses should remain compatible when several stresses act at once.

    Rests on: The goal of restoring skin function is narrowed to preserving protection during simultaneous stresses.

    Assumption

    Compatibility between protective responses is taken as a component of younger skin function; the preceding goal does not establish that connection.

  3. Gap questionstep 03 of 04

    Equal itch relief might conceal different levels of protection: removing a tissue irritant might preserve warning of increasing heat and pressure, while reducing nerve responsiveness might allow greater exposure before discomfort despite hidden injury.

    Rests on: The preceding stage calls for protective responses to work together under simultaneous stresses; this question makes that requirement concrete through itch relief, heat, pressure and warning of injury.

    Stated in the chain
  4. Hypothesisstep 04 of 04

    Selecting participants with equal itch improvement after treatment could create the apparent disadvantage of reducing nerve activity. Treatment choice, starting and skin damage are proposed to influence itch improvement, so selection could leave groups with different starting risks even after .

    Rests on: The preceding comparison holds itch improvement equal. The hypothesis supplies a reason that this restriction could distort the comparison, and predicts no additional loss of protective time from the studied symptom treatment when the comparison includes everyone assigned.

    Assumption

    The proposed explanation assumes that starting and skin damage influence both selection through itch improvement and the risk of late warning or injury strongly enough to account for the apparent treatment difference. Those relationships are stated in the hypothesis but are not established by the preceding stages or screened sources.

What is carried, and what is not. None of the five screened sources directly supports a link in the proposed selection mechanism. The supplied abstract from Dermatologic Therapy (2005, S3) describes itch as a defensive alarm sensation, but does not examine treatment selection, or skin injury; neither that background nor the other supplied sources establishes the proposed sequence end to end.S3

Where the reasoning is carried by something unstated · 3
  • Master question. The goal assumes that younger skin function provides a suitable treatment target; the supplied material gives no operational definition of that target.
  • Goal pillar. Compatibility between protective responses is taken as a component of younger skin function; the preceding goal does not establish that connection.
  • Hypothesis. The proposed explanation assumes that starting and skin damage influence both selection through itch improvement and the risk of late warning or injury strongly enough to account for the apparent treatment difference. Those relationships are stated in the hypothesis but are not established by the preceding stages or screened sources.
How a result here could mislead · 3
  • A difference too imprecisely measured to be detected could be mistaken for evidence that the treatments preserve the same warning time. What closes it: , the largest differences considered clinically acceptable, must be fixed before analysis, and the comparison must be precise enough to place the estimated differences within them. Merely failing to detect a difference does not establish equivalence.
  • Similar warning times could be mistaken for similar protection even if injury begins at different times. The rival explanations allow to delay injury or impaired to advance it. What closes it: and injury timing must be assessed separately under recorded exposure. The , the interval between warning and injury, needs a specified calculation and injury criterion; neither is supplied here.
  • A difference that appears after selecting equal itch responders could be credited entirely to selection even if treatment actually has different effects in people with different starting skin conditions. What closes it: The proposed repeated starting measurements must support a prespecified examination of whether treatment effects differ with initial and skin damage. Changing selection rules alone cannot establish that the entire difference is an artifact.

What would make this wrong. A persistent treatment-caused shortening of the in a sufficiently precise comparison retaining all randomly assigned participants would reject the claim that selection entirely explains the apparent disadvantage. That conclusion requires verified treatment exposure and separate, adequately defined measurements of warning and injury.

What it would change. If the hypothesis held, an apparent safety advantage from removing irritants could be a consequence of selecting participants rather than a treatment effect. Work toward restoring younger skin function would need to judge protection using the full assigned groups and the timing of warning relative to injury, with equal itch relief described as an outcome. That would still not establish restored youthful skin function, long-term safety, or effects beyond the particular treatments and exposures studied; the supplied test description does not specify its population.

Sources read · 5

3 literature searches, 6 full texts, 4 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S2Background

Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies. · Archives of dermatological research · 2024

“The proportion of patients who had ≥ 4point improvement in NRS worst daily itch score, among those with baseline NRS ≥ 4, was 52.2% (12/23) and 32.0% (8/25) at week 16 for bermekimab 400 mg qw and 400 mg q2w, respectively, with no significant difference from placebo (53.8%; 14/26; P = 0.99 and P = 0.09, respectively).”

Does not settle: Источник не оценивает отбор участников по одинаковому уменьшению зуда, исходную сенсорную функцию, позднее предупреждение о повреждении кожи, защитный временной запас или причинный эффект подавления нервов.

S3BackgroundAbstract only

Itch, pain, and metaesthetic sensation. · Dermatologic therapy · 2005

“Itch is one of the alarm sensations that human beings have phylogenetically evolved for a defense purpose.”

Does not settle: Источник не изучает отбор участников по одинаковому уменьшению зуда, сравнение вмешательств, исходную сенсорную функцию, позднее предупреждение или повреждение кожи.

S4Background

Sodium channels Nav1.7, Nav1.8 and pain; two distinct mechanisms for Nav1.7 null analgesia. · Neurobiology of pain (Cambridge, Mass.) · 2024

“The lack of therapeutic window and autonomic side effects of potent selective Nav1.7 channel blockers contrasts with the apparent normality of embryonic Nav1.7 null mice and humans ( ).”

Does not settle: Источник не рассматривает зуд, устранение кожных раздражителей, отбор участников по уменьшению зуда, исходную сенсорную функцию, тяжесть поражения кожи, позднее предупреждение или повреждение. Он не проверяет гипотезу об отсутствии дополнительного сокращения защитного временного запаса при симптоматическом лечении.

S6Background

An SCN9A channelopathy causes congenital inability to experience pain. · Nature · 2006

“All had injuries to their lips (some requiring later plastic surgery) and/or tongue (with loss of the distal third in two cases), caused by biting themselves in the first 4 yr of life.”

Does not settle: Источник оставляет открытыми эффект симптоматического лечения, устранение кожных раздражителей, зуд, отбор участников по улучшению зуда, исходную сенсорную функцию, тяжесть кожного поражения и защитный временной запас.

S9Background

Antipruritic Placebo Effects by Conditioning H1-antihistamine. · Psychosomatic medicine · 2019

“The current study investigated whether behavioral conditioning of the antihistaminergic properties of levocetirizine could reduce itch in response to a short-term histamine challenge.”

Does not settle: Источник не оценивает отбор участников по уменьшению зуда, исходную сенсорную функцию, позднее предупреждение или повреждение кожи, а также специфическое влияние симптоматического лечения на защитной временной запас.

The gap this hypothesis explains

What is measured here stands in for what matters, and may not track it.

At equal itch relief, does removing irritation preserve heat and pressure warnings while calming nerves conceals injury?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

При одинаковом уменьшении зуда сохраняется ли предупреждение о нарастающем тепле и давлении только после устранения , тогда как снижение увеличивает переносимую нагрузку ценой скрытого повреждения?

What this question is asking

The question concerns whether equally effective itch relief can have different consequences for the skin’s ability to warn of injury. It compares removing a tissue irritant with reducing nerve excitability, meaning how readily nerves produce electrical signals, while holding the reduction in itch equal. The proposed distinction is that removing irritation preserves warning sensations during increasing heat and pressure, whereas reducing nerve activity allows greater exposure before discomfort stops it, potentially concealing injury. The intended comparison concerns middle-aged human skin, with warnings occurring seconds or minutes before damage and within a young-adult reference range; these are proposed requirements, not results established by the supplied sources.

What the terms mean
Tissue irritant
Something that provokes irritation in skin tissue. The input does not identify a particular irritant or establish that removing it repairs existing injury.
Nerve excitability
How readily a nerve cell produces electrical signals in response to stimulation. It is a variable property, not a simple on-or-off state; reducing it does not by itself establish which sensations will change.
Sensory nerve cells
Nerve cells that carry information about bodily conditions or external stimulation. Their electrical responsiveness is measured in S8, but the supplied finding does not measure warning time before skin injury.
Sodium channel Nav1.7
A voltage-gated sodium channel, subtype 1.7: a protein through which sodium passes across a nerve cell’s outer membrane to contribute to electrical signaling. S8 links loss of its electrical current to reduced nerve excitability in mice.
Protective warning and warning time
Here, a protective warning means a sensation that signals potentially damaging exposure early enough for action. Warning time is the interval between that sensation and the beginning of injury; neither the required interval nor its preservation is demonstrated in the supplied sources.
Tolerated exposure
The amount or duration of heat or pressure endured before exposure stops. This is distinct from the amount that tissue can withstand without injury.
Hidden injury
Tissue damage that occurs without a sufficient warning sensation. It is a proposed outcome in the question, not a reported finding in the supplied evidence.
Heat-pain detection threshold
The point during heat stimulation at which pain is first detected. It measures perception and does not, by itself, identify when tissue damage begins.
Sensitive skin
The skin condition used to describe the people discussed in S3. The supplied material does not give its defining criteria or establish that this group represents middle-aged skin generally.
Inflamed tissue
Tissue undergoing an inflammation response. S1 discusses increased itch and pain sensitivity in this setting without establishing the treatment comparison in the question.
Spinal cord
The part of the nervous system within the spine that helps transmit and process sensory signals. S1 identifies it as another location where related patterns of increased itch and pain sensitivity occur.
Young-adult reference range
A comparison range intended to describe warning times in younger adults. The input specifies this as a desired benchmark but supplies no measurements or age boundaries defining it.
What the question takes for granted
Premise could not be checked
Removing a tissue irritant preserves protective warnings about increasing heat and pressure, whereas reducing nerve excitability increases tolerated exposure at the cost of hidden injury, even when itch relief is equal.

A tissue irritant is something that provokes irritation in the skin, while nerve excitability describes how readily nerves send electrical signals. The assumption is that removing the irritant leaves danger signals intact, but making nerves less responsive suppresses those signals without preventing damage. If established, this distinction would explain why the same improvement in itch could represent either safer skin function or concealed injury.

S8 supports a narrower mechanism: loss of sodium channel current reduced the excitability of sensory nerve cells in mice. It does not establish delayed warnings, greater tolerated exposure, hidden injury, or a comparison with irritant removal at equal itch relief. S3 reports a changed heat-pain detection threshold in people with sensitive skin, but the supplied quote gives neither its direction nor its relationship to injury. The supplied reading is too indirect to establish or refute the proposed contrast.S8S3

The same question asked without the part nothing read establishes:

  • At equal itch relief, how do removing a skin irritant and reducing nerve excitability differ in warning time before heat and pressure cause injury?
  • At equal itch relief in middle-aged adults, do either of these approaches preserve warning time before skin injury within a young-adult reference range?
What turns on the answer
  • Only irritant removal preserves warnings If reducing nerve activity delays warnings while injury begins at the same exposure, the interval available for protective action would shrink. Greater tolerated exposure would then conceal vulnerability, whereas irritant removal would provide itch relief with warning function preserved.
  • Both approaches preserve warnings If both approaches leave sufficient time between warning and injury, reducing nerve activity would not necessarily sacrifice this protective function. Equal itch relief could then coexist with preserved warnings through either route, weakening the proposed exclusive advantage of irritant removal.
  • Neither approach preserves warnings If warnings remain too late after both approaches, removing the irritant would not by itself establish recovery of protective sensation. Symptom improvement through either route could therefore overstate restoration of skin function.
  • Only reduced nerve activity preserves warnings If reducing nerve activity preserves warning time while irritant removal does not, the proposed ordering would be reversed. Removing irritation would then be insufficient evidence of preserved protection, and reduced nerve activity would not imply concealed injury.
Why it matters

The question treats an unpleasant sensation as a possible warning that allows exposure to heat or pressure to stop before tissue is injured. If itch relief also delays that warning, greater tolerated exposure could reflect weaker sensation rather than greater resistance to injury. If removing irritation relieves itch while preserving warning time, symptom relief and protection could instead coexist. Mistaking either pattern for the other would make itch reduction or tolerated exposure an unreliable measure of restored skin function; these are conditional consequences of the question’s proposed mechanism.

What is already established

Подавление RL-2 может ослаблять ; уменьшение RL-3 не устанавливает сохранность предупреждения при .

What would have to be true

При приемлемом зуде предупреждающее ощущение должно возникать за секунды или минуты до повреждения, в пределах .

What is missing

Одинаковое снижение симптомов не различает восстановление ткани и маскировку опасной нагрузки; требуется измерение времени для защитного действия.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Предполагаемое преимущество устранения при одинаковом уменьшении зуда может целиком возникать из-за . На уменьшение зуда одновременно влияют выбранное , исходная и тяжесть поражения кожи. Если после лечения оставить только участников с одинаковым улучшением, группы могут различаться по позднего предупреждения и повреждения даже после . В это создаёт видимость . Гипотеза утверждает отсутствие специфического дополнительного сокращения при изучаемом режиме после корректного сравнения. Она не отрицает потерю при полном выключении .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

В исследовании с распределением до лечения и анализом всех включённых участников различие в и расчётном укладывается в заранее заданные . Повторный анализ только участников с одинаковым снижением зуда воспроизводит исходное различие. Его величина меняется при изменении правил отбора. В лабораторном сравнении тканей при фиксированной нагрузке ни , ни продуктивность не объясняют устойчивого различия между . Сохранение в полном отвергает эту гипотезу.

Would tell it apart from at least one rival. The text specifies equivalence bounds, reproducibility under participant selection, variation with selection rules, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Проверка возможна при заранее заданном анализе клинически допустимых , повторных и регистрации фактического воздействия. Равное уменьшение зуда следует описывать как результат, а не использовать как единственный в сравнение. Нужны и достаточная точность; отсутствие различий само по себе гипотезу не подтверждает.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

В исследовании с распределением до лечения и анализом всех включённых участников различие в и расчётном укладывается в заранее заданные . Повторный анализ только участников с одинаковым снижением зуда воспроизводит исходное различие. Его величина меняется при изменении правил отбора. В лабораторном сравнении тканей при фиксированной нагрузке ни , ни продуктивность не объясняют устойчивого различия между . Сохранение в полном отвергает эту гипотезу.

  • What would separate them

    Nerve-triggered mast cell proteases may be required for initial skin injury under heat and pressure predicts: В при одинаковых температуре внутри ткани, давлении, и длительности воздействия подавление предотвращает первое необратимое повреждение . Добавление активных возвращает повреждение при сохранённом подавлении ; такого эффекта не дают. воспроизводит защиту при сохранённой нервной активности. Гипотеза отвергается, если меняют только позднее воспаление, а начало гибели клеток остаётся прежним. У людей ожидается сохранение или увеличение расчётного времени между предупреждением и повреждением даже после уменьшения .

  • What would separate them

    Poor coupling of energy use to protein repair may shorten skin’s warning time before damage predicts: При одинаковых тканевой нагрузке, нервной активности и изменение соотношения кофакторов меняет время до повреждения. Восстановление увеличивает этот интервал без сдвига ; ускорение без улучшения восстановления белков защиты не даёт. В тот же дефект воспроизводится при фиксированных концентрациях и . Отсутствие эффекта после подтверждённого восстановления работы отвергает гипотезу как основное объяснение данного расхождения.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.